Cited by 1,052Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchPharmacological Receptor Mechanisms and Effects

The DOI matches its Crossref record; 64 of the 68 references it cites were found in a registry or an index.

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

Glass, M, Faull, R.L.M, Dragunow, M·1997·Neuroscience

DOI 10.1016/s0306-4522(96)00428-9

Open this paper in CoChat — free account

Abstract

The anatomical distribution and density of cannabinoid receptors in the human brain was studied in one fetal (33 weeks gestation), two neonatal (aged three to six months) and eight adult (aged 21-81 years) human cases using quantitative receptor autoradiography following in vitro labelling of sections with the synthetic cannabinoid agonist [3H]CP55,940. Cannabinoid receptors were distributed in a heterogeneous fashion throughout the adult human brain and spinal cord. The allocortex contained very high concentrations of cannabinoid receptor binding sites in the dentate gyrus, Ammons's horn and subiculum of the hippocampal formation; high concentrations of receptors were also present in the entorhinal cortex and amygdaloid complex. Cannabinoid receptor binding sites were also present throughout all regions of the neocortex, where they showed a marked variation in density between the primary, secondary and associational cortical regions: the greatest densities of receptors were present in the associational cortical regions of the frontal and limbic lobes, with moderate densities in the secondary sensory and motor cortical regions, and with the lowest densities of receptors in the primary sensory and motor cortical regions. Relatively high concentrations of cannabinoid receptors were consistently seen in cortical regions of the left (dominant) hemisphere, known to be associated with verbal language functions. In all of the cortical regions, the pattern and density of receptor labelling followed the neocortical laminar organization, with the greatest density of receptors localized in two discrete bands--a clearly delineated narrow superficial band which coincided with lamina I and a deeper broader, conspicuous band of labelling which corresponded to laminae V and VI. Labelling in the intervening cortical laminae (II-IV) showed lower densities, with a well delineated narrow band of label in the middle of laminae IV in the associational cortical regions. The thalamus showed a distinctive heterogeneous distribution of cannabinoid receptors, with the highest concentration of receptors localized in the mediodorsal nucleus, anterior nuclear complex, and in the midline and intralaminar complex of nuclei, i.e. in thalamic nuclei which have connectional affiliations with the associational cortical areas. The basal ganglia showed a distinctive heterogeneous pattern of receptor binding, with the very highest concentrations in the globus pallidus internus, moderate concentrations in the globus pallidus externus and ventral pallidum, and moderately low levels of binding throughout the striatal complex. In the midbrain, some of the highest levels of cannabinoid receptor binding sites in the human brain were present in the substantia nigra pars reticulata, with very low levels of labelling in all other midbrain areas. The highest densities of cannabinoid receptor binding in the hindbrain were localized in the molecular layer of the cerebellar cortex and the dorsal motor nucleus of the vagus, with moderate densities of receptors in the nucleus of the solitary tract. The spinal cord showed very low levels of receptor binding. Studies on the distribution of cannabinoid receptors in the fetal and neonatal human brain showed similar patterns of receptor distribution to that observed in the adult human brain, except that the density of receptor binding was generally markedly higher, especially in the basal ganglia and substantia nigra. The pattern of cannabinoid receptor labelling in the striatum showed a striking patchy pattern of organization which was especially conspicuous in the fetal brain. These results show that cannabinoid receptor binding sites in the human brain are localized mainly in: forebrain areas associated with higher cognitive functions; forebrain, midbrain and hindbrain areas associated with the control of movement; and in hindbrain areas associated with the control of motor and sensory functions of the autonomic nervous system. (AB

Integrity signals

Registry

Crossref · 10.1016/s0306-4522(96)00428-9

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
The Thalamus
Jones, E. G. (1985) · Springer eBooks · doi:10.1007/978-1-4615-1749-8 · Cited by 1,164
Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining
Graybiel, A. M., & Ragsdale, C. W. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5723 · Cited by 784
Laminar Organization of Thalamic Projections to the Rat Neocortex
Herkenham, M. A. (1980) · Science · doi:10.1126/science.7352263 · Cited by 595
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M. A., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515
Health aspects of cannabis
Hollister, L. E. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 500

Show all 68 references

Research works printed but not linked: 9

Bidaut-Russell, 1989, Opioid and cannabinoid analgetics both inhibit cyclic AMP production in the rat striatum, Adv. Biosci., 75, 165
Campbell, 1986, Delta-9-tetrahydrocannabinol differentially affects sensory-evoked potentials in the rat detate gyrus, J. Pharmac. exp. Ther., 239, 941
Chen, 1993, Transient concentration of cannabinoid receptors in the cortex subplate zone during kitten post-natal development, Soc. Neurosci. Abstr., 19, 305
Devane, 1988, Determination and characterisation of a cannabinoid receptor in rat brain, Molec. Pharmac., 34, 605
Dewey, 1972, The effects of chronic administration of trans-delta-9-tetrahydorcannibinol on behaviour and the cardiovascular system of dogs, Archs int. Pharmacodyn. Thér., 198, 118
Edery, 1972, Structure activity relationships in the tetrahydrocanabinol species, Arzneimittel-Forshch., 22, 1995
Howlett, 1985, Cannabinoid inhibition of adenylate cyclase. Biochemistry of response in neuroblasta cell membrane, Molec. Pharmac., 27, 429
Howlett, 1986, Involvement of Gi in the inhibition of adenylate cyclase by cannabinoid drugs, Molec. Pharmac., 29, 307
Mendelson, 1976, Operant acquisition of marijuana by men, J. Pharmac. exp. Ther., 198, 42

Sorted by citations

Items 501–600 of 1,000

Modulation of Network Oscillatory Activity and GABAergic Synaptic Transmission by CB1 Cannabinoid Receptors in the Rat Medial Entorhinal Cortex
Morgan, N. H., Stanford, I. M., & Woodhall, G. L. (2008) · Neural Plasticity · doi:10.1155/2008/808564 · Cited by 27
Cannabis‐induced propriospinal myoclonus
Lozsádi, D. A., Forster, A. M., & Fletcher, N. A. (2004) · Movement Disorders · doi:10.1002/mds.10696 · Cited by 27
Characterization of NTera2/D1 cells as a model system for the investigation of cannabinoid function in human neurons and astrocytes
Goodfellow, C. E., Graham, S. E., Dragunow, M., & Glass, M. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22692 · Cited by 27
Self-citation
Disrupted Gamma-Band Neural Oscillations During Coherent Motion Perception in Heavy Cannabis Users
Skosnik, P. D., Krishnan, G. P., D’Souza, D. C., Hetrick, W. P., & O’Donnell, B. F. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.166 · Cited by 27
The Hypothalamus and Obesity
Harrold, J. A., & Halford, J. C. G. (2006) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488906778773616 · Cited by 27
Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting
Potvin, S., Mahrouche, L., Assaf, R., Chicoine, M., Giguère, C., Fürtös, A., & Godbout, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00628 · Cited by 28
The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
Tudorancea, I. M., Ciorpac, M., Stanciu, G. D., Caratașu, C.-C., Săcărescu, A., Ignat, B. E., Burlui, A., Rezuş, E., Creangă-Murariu, I., Alexa‐Stratulat, T., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10102492 · Cited by 28
Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC
Oultram, J. M. J., Pegler, J. L., Bowser, T. A., Ney, L. J., Eamens, A. L., & Grof, C. P. L. (2021) · Biomedicines · doi:10.3390/biomedicines9030234 · Cited by 30
Impact of the Cannabinoid System in Alzheimer's Disease
Li, S., Huang, Y., Yu, L., Ji, X., & Wu, J. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220201091006 · Cited by 28
Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility
Przybycień, P., Gąsior‐Perczak, D., & Placha, W. (2022) · Cells · doi:10.3390/cells11162569 · Cited by 26
The decrease of dopamine D2/D3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB1 cannabinoid receptors in Parkinson's disease: A preliminary autoradiographic study with the selective dopamine D2/D3 antagonist [3H]raclopride and the novel CB1 inverse agonist [125I]SD7015
Farkas, S., Nagy, K., Jia, Z., Harkany, T., Palkovits, M., Donohou, S. R., Pike, V. W., Halldin, C., Máthé, D., Csiba, L., et al. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.02.012 · Cited by 26
Cannabinoids to treat spinal cord injury
Arévalo‐Martín, Á., Molina‐Holgado, E., & García‐Ovejero, D. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.008 · Cited by 27
Effects of nicotine and a cannabinoid receptor agonist on negative contrast: distinction between anxiety and disappointment?
Genn, R. F., Tucci, S. A., Parikh, S., & File, S. E. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1932-5 · Cited by 26
Frontal Assessment Battery (FAB) is a simple tool for detecting executive deficits in chronic cannabis users
Fontes, M. A., Bolla, K. I., Cunha, P. J., Almeida, P. P., Jungerman, F. S., Laranjeira, R., Bressan, R. A., & Lacerda, A. L. T. (2011) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2010.535505 · Cited by 26
Developmental pattern of CB1cannabinoid receptor immunoreactivity in brain regions important to zebra finch (Taeniopygia guttata) song learning and control
Soderstrom, K., & Tian, Q. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20963 · Cited by 26
Inhibition of Potassium- and Ischemia-Evoked [3H] D -Aspartate Release from Isolated Bovine Retina by Cannabinoids
Opere, C. A., Zheng, W. D., Zhao, M., Lee, J. S., Kulkarni, K. H., & Ohia, S. E. (2006) · Current Eye Research · doi:10.1080/02713680600762747 · Cited by 26
Chemical Tools for Studying Lipid-Binding Class A G Protein–Coupled Receptors
Cooper, A. G., Singh, S., Hook, S. M., Tyndall, J. D. A., & Vernall, A. J. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013243 · Cited by 26
The Influence of DAT1, COMT, and BDNF Genetic Polymorphisms on Total and Subregional Hippocampal Volumes in Early Onset Heavy Cannabis Users
Batalla, A., Lorenzetti, V., Chye, Y., Yücel, M., Soriano‐Mas, C., Bhattacharyya, S., Torrens, M., Crippa, J. A. S., & Martín‐Santos, R. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0021 · Cited by 26
Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder
Poleg, S., Kourieh, E., Ruban, A., Shapira, G., Shomron, N., Barak, B., & Offen, D. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01612-3 · Cited by 27
The Endocannabinoid System: An Osteopathic Perspective
McPartland, J. M. (2008) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2008.108.10.586 · Cited by 26
Effects of Cannabis on Glutamatergic Neurotransmission: The Interplay between Cannabinoids and Glutamate
Chowdhury, K. U., Holden, M. E., Wiley, M. T., Suppiramaniam, V. D., & Reed, M. N. (2024) · Cells · doi:10.3390/cells13131130 · Cited by 25
Virtual library docking for cannabinoid-1 receptor agonists with reduced side effects
Tummino, T. A., Iliopoulos‐Tsoutsouvas, C., Braz, J. M., O’Brien, E. S., Stein, R. M., Craik, V., Tran, N. K., Ganapathy, S., Liu, F., Shiimura, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57136-7 · Cited by 25
Anandamide prior to sensitization increases cell-mediated immunity in mice
Ribeiro, A., Ferraz-de-Paula, V., Pinheiro, M. L., Sakai, M., Costa‐Pinto, F. A., & Palermo‐Neto, J. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2009.12.017 · Cited by 25
Synaptic effects of cannabinoids
Benarroch, E. E. (2014) · Neurology · doi:10.1212/wnl.0000000000001013 · Cited by 25
Developmental expression of cannabinoid receptors in the chick retinotectal system
Leonelli, M., Britto, L. R. G., Chaves, G. P., & Torrão, A. D. S. (2005) · Developmental Brain Research · doi:10.1016/j.devbrainres.2005.02.009 · Cited by 25
Neuroreceptor Imaging Studies in Schizophrenia
Frankle, W. G. (2007) · Harvard Review of Psychiatry · doi:10.1080/10673220701679812 · Cited by 25
Aerobic Exercise and Endocannabinoids: A Narrative Review of Stress Regulation and Brain Reward Systems
Gupta, S., Bharatha, A., Cohall, D., Rahman, S., Haque, M., & Majumder, M. A. A. (2024) · Cureus · doi:10.7759/cureus.55468 · Cited by 26
Chronic Cannabis Use and Axonal Fiber Connectivity
Solowij, N., Zalesky, A., Lorenzetti, V., & Yücel, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00046-6 · Cited by 24
Brain endocannabinoid signaling exhibits remarkable complexity
Gorzkiewicz, A., & Szemraj, J. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.012 · Cited by 26
On the Role of Central Type-1 Cannabinoid Receptor Gene Regulation in Food Intake and Eating Behaviors
Pucci, M., Zaplatić, E., Bonaventura, M. V. M. D., Bonaventura, E. M. D., Cristofaro, P. D., Maccarrone, M., Cifani, C., & D’Addario, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010398 · Cited by 27
New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type‐1 cannabinoid receptor (CB1R) activity and function
Raux, P., Drutel, G., Revest, J., & Vallée, M. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13034 · Cited by 24
Prevalence and characteristics of cannabis-induced toxicoses in pets: Results from a survey of veterinarians in North America
Amissah, R. Q., Vogt, N. A., Chen, C., Urban, K., & Khokhar, J. Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0261909 · Cited by 24
Individual and combined effects of cannabidiol and Δ 9 -tetrahydrocannabinol on striato-cortical connectivity in the human brain
Wall, M. B., Freeman, T. P., Hindocha, C., Demetriou, L., Ertl, N., Freeman, A. M., Jones, A., Lawn, W., Pope, R. A., Mokrysz, C., et al. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221092506 · Cited by 24
Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet
Donat, C. K., Fischer, F., Walter, B. L., Deuther‐Conrad, W., Brodhun, M., Bauer, R., & Brust, P. (2014) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2014-1985 · Cited by 24
The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data
Gouvêa, E. S., Filho, A. F. D. S., Ota, V., Mrad, V. C., Gadelha, A., Bressan, R. A., Cordeiro, Q., & Belangero, S. I. (2017) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2016-1969 · Cited by 25
Association of Marijuana Use with Changes in Cognitive Processing Speed and Flexibility for 17 Years in HIV-Seropositive and HIV-Seronegative Men
Okafor, C. N., Plankey, M. W., Li, M. J., Chen, X., Surkan, P. J., SHOPTAW, S. J., Martin, E. M., Cohen, R. A., Sacktor, N. C., & Cook, R. L. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2018.1495736 · Cited by 24
The novel MAGL inhibitor MJN110 enhances responding to reward-predictive incentive cues by activation of CB1 receptors
Feja, M., Leigh, M. P. K., Baindur, A. N., McGraw, J. J., Wakabayashi, K. T., Cravatt, B. F., & Bass, C. E. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107814 · Cited by 25
Novel object recognition memory in REM sleep-deprived rats: Role of the cannabinoid CB1 receptor
Shahveisi, K., Farnia, V., Khazaie, H., Ghazvini, H., Nozari, M., & Khodamoradi, M. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112311 · Cited by 24
Feasibility of central cannabinoid CB1 receptor imaging with [124I]AM281 PET demonstrated in a schizophrenic patient
Berding, G., Schneider, U., Gielow, P., Buchert, R., Donnerstag, F. G. F., Brandau, W., Knapp, W. H., Emrich, H. M., & Müller‐Vahl, K. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.02.002 · Cited by 24
Acute and chronic effects of Δ9-tetrahydrocannabinol (THC) on cerebral blood flow: A systematic review
Ogunbiyi, O., Hindocha, C., Freeman, T. P., & Bloomfield, M. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109900 · Cited by 23
Acute effects of delta-9-tetrahydrocannabinol on performance monitoring in healthy volunteers
Spronk, D. B. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00059 · Cited by 24
Augmentation of Evidence-Based Psychotherapy for PTSD With Cognitive Enhancers
Marin, M., Lonak, S. F., & Milad, M. R. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0582-0 · Cited by 24
Substance abuse, hepatitis C, and aging in HIV: common cofactors that contribute to neurobehavioral disturbances
González, R., & Schuster (2012) · Neurobehavioral HIV Medicine · doi:10.2147/nbhiv.s17408 · Cited by 23
Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia
Chase, K. A., Feiner, B., Rosen, C., Gavin, D. P., & Sharma, R. P. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.08.055 · Cited by 23
Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report
Pichler, E. M., Kawohl, W., Seifritz, E., & Roser, P. (2018) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217418791455 · Cited by 23
Intrinsic Frontolimbic Connectivity and Mood Symptoms in Young Adult Cannabis Users
Shollenbarger, S. G., Thomas, A. M., Wade, N. E., Gruber, S. A., Tapert, S. F., Filbey, F. M., & Lisdahl, K. M. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00311 · Cited by 24
Zerumbone Ameliorates Neuropathic Pain Symptoms via Cannabinoid and PPAR Receptors Using In Vivo and In Silico Models
Chia, J. S. M., Farouk, A. A. O., Mohamad, T. A. S. T., Sulaiman, M. R., Zakaria, H., Hassan, N. I., & Perimal, E. K. (2021) · Molecules · doi:10.3390/molecules26133849 · Cited by 23
Endogenous Cannabinoid Receptor Agonists Inhibit Neurogenic Inflammations in Guinea Pig Airways
Yoshihara, S., Morimoto, H., Ohori, M., Yamada, Y., Abe, T., & Arisaka, O. (2005) · International Archives of Allergy and Immunology · doi:10.1159/000087361 · Cited by 23
Measuring white matter microstructure in 1,457 cannabis users and 1,441 controls: A systematic review of diffusion-weighted MRI studies
Robinson, E. A., Gleeson, J., Arun, A. H., Clemente, A., Gaillard, A., Rossetti, M. G., Brambilla, P., Bellani, M., Crisanti, C., Curran, H., et al. (2023) · Frontiers in Neuroimaging · doi:10.3389/fnimg.2023.1129587 · Cited by 22
Neuroanatomical substrates involved in cannabinoid modulation of defensive responses
Moreira, F. A., Aguiar, D., Resstel, L. B. M., Lisboa, S. F. D. S., Campos, A. C., Gomes, F. V., & Guimarães, F. S. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111400651 · Cited by 24
Cannabinoid-1 receptors in the mouse ventral pallidum are targeted to axonal profiles expressing functionally opposed opioid peptides and contacting N-acylphosphatidylethanolamine-hydrolyzing phospholipase D terminals
Pickel, V., Shobin, E., Lane, D., & Mackie, K. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.050 · Cited by 22
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells
Stanslowsky, N., Jahn, K., Venneri, A., Naujock, M., Haase, A., Martin, U., Frieling, H., & Wegner, F. (2016) · Addiction Biology · doi:10.1111/adb.12394 · Cited by 22
Cannabinoid Receptor Agonists Inhibit Sensory Nerve Activation in Guinea Pig Airways
Yoshihara, S., Morimoto, H., Yamada, Y., Abe, T., & Arisaka, O. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200306-775oc · Cited by 22
Involvement of the endocannabinoid system in alcohol dependence: The biochemical, behavioral and genetic evidence
Erdozain, A. M., & Callado, L. F. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.02.003 · Cited by 21
Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 25
Prenatal Cannabis Exposure and Executive Function and Aggressive Behavior at Age 5 Years
Keim, S. A., Fried, P. A., Yeates, K. O., Boone, K. M., Vrantsidis, D. M., Dean, A., Murnan, A., Rausch, J. R., & Klebanoff, M. A. (2024) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2024.4352 · Cited by 23
Cannabinoids in Health and Disease
Meccariello, R., & Chianese, R. (2016) · InTech eBooks · doi:10.5772/61595 · Cited by 22
Sex differences in alcohol consumption and alterations in nucleus accumbens endocannabinoid mRNA in alcohol-dependent rats
Henricks, A. M., Berger, A. L., Lugo, J. M., Baxter-Potter, L. N., Bieniasz, K. V., Craft, R. M., & McLaughlin, R. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.032 · Cited by 22
Adolescent‐onset heavy cannabis use associated with significantly reduced glial but not neuronal markers and glutamate levels in the hippocampus
Blest‐Hopley, G., O’Neill, A., Wilson, R. P., Giampietro, V., Lythgoe, D. J., Egerton, A., & Bhattacharyya, S. (2019) · Addiction Biology · doi:10.1111/adb.12827 · Cited by 22
Episodic foresight deficits in regular, but not recreational, cannabis users
Mercuri, K., Terrett, G., Henry, J. D., Curran, H. V., Elliott, M., & Rendell, P. G. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118776672 · Cited by 21
Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date
Chalhoub, R., & Kalivas, P. W. (2020) · Drugs · doi:10.1007/s40265-020-01373-1 · Cited by 20
Associations of cannabis use disorder with cognition, brain structure, and brain function in African Americans
Koenis, M. M. G., Durnez, J., Rodrigue, A., Mathias, S. R., Alexander‐Bloch, A. F., Barrett, J. A., Doucet, G. E., Frangou, S., Knowles, E. E. M., Mollon, J., et al. (2020) · Human Brain Mapping · doi:10.1002/hbm.25324 · Cited by 21
Endocannabinoid System Changes throughout Life: Implications and Therapeutic Potential for Autism, ADHD, and Alzheimer’s Disease
Dallabrida, K. G., Bender, J. M. D. O., Chade, E. S., Rodrigues, N., & Sampaio, T. B. (2024) · Brain Sciences · doi:10.3390/brainsci14060592 · Cited by 21
Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors
Zádor, F., Ötvös, F., Benyhe, S., Zimmer, A., & Páldy, E. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.05.015 · Cited by 20
Endocannabinoid signalling in stem cells and cerebral organoids drives differentiation to deep layer projection neurons via CB1 receptors
Paraíso‐Luna, J., Aguareles, J., Martín, R., Ayo-Martin, A. C., Simón-Sánchez, S., García-Rincón, D., Costas‐Insua, C., García-Taboada, E., de Salas-Quiroga, A., Díaz-Alonso, J., et al. (2020) · Development · doi:10.1242/dev.192161 · Cited by 21
Integrating Endocannabinoid Signalling In Depression
Rana, T., Behl, T., Sehgal, A., Mehta, V., Singh, S., Kumar, R., & BUNGAU, S. G. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01774-7 · Cited by 20
Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
Wilkerson, J. L., Bilbrey, J. A., Felix, J. S., Makriyannis, A., & McMahon, L. R. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173192 · Cited by 20
Effects of prenatal exposure to the CB-1 receptor agonist WIN 55212-2 or CO on the GABAergic neuronal systems of rat cerebellar cortex
Benagiano, V., Lorusso, L., Flace, P., Girolamo, F., Rizzi, A., Sabatini, R., Auteri, P., Bosco, L., Cagiano, R., & Ambrosi, G. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.050 · Cited by 20
Exposure to cannabinoids in the development of endogenous cannabinoid system
Ramos, J. A., de Miguel, R., Cebeira, M., Hernández, M., & Fernández‐Ruíz, J. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000010893 · Cited by 20
Fatty acid amide hydrolase inhibition alleviates anxiety-like symptoms in a rat model used to study post-traumatic stress disorder
Fotio, Y., Tagne, A. M., Jung, K., & Piomelli, D. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06358-y · Cited by 19
Allosteric Modulation of the Cannabinoid CB1 Receptor
Cawston, E. E., Hunter, M. R., & Glass, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00070-3 · Cited by 19
Self-citation
Dietary Galacto‐Oligosaccharides and Resistant Starch Protect Against Altered CB1 and 5‐HT1A and 2A Receptor Densities in Rat Brain: Implications for Preventing Cognitive and Appetite Dysfunction During a High‐Fat Diet
Yu, Y., Patch, C. S., Weston–Green, K., Zhou, Y., Zheng, K., & Huang, X. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800422 · Cited by 19
Interaction of Cannabis Use and Aging: From Molecule to Mind
Yoo, H. B., DiMuzio, J. M., & Filbey, F. M. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1665218 · Cited by 21
Cognition and Cortical Thickness in Heavy Cannabis Users
Wittemann, M., Brielmaier, J., Rubly, M., Kennel, J., Werler, F., Schmitgen, M. M., Kubera, K. M., Hirjak, D., Wolf, N. D., Reith, W., et al. (2020) · European Addiction Research · doi:10.1159/000509987 · Cited by 20
Endocannabinoid system reactivity during stress processing in healthy humans
Spohrs, J., Prost, M., Martin, U., Plener, P. L., Bîndilă, L., & Abler, B. (2022) · Biological Psychology · doi:10.1016/j.biopsycho.2022.108281 · Cited by 21
The Cannabinoid Receptor Agonist WIN 55,212-2 Inhibits Antigen-Induced Plasma Extravasation in Guinea Pig Airways
Fukuda, H., Abe, T., & Yoshihara, S. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000283042 · Cited by 19
PET Imaging Studies in Rhesus Monkey with the Cannabinoid-1 (CB1) Receptor Ligand [11C]CB-119
Hamill, T. G., Lin, L. S., Hagmann, W. K., Liu, P., Jewell, J. P., Sanabria, S., Eng, W., Ryan, C. N., Fong, T. M., Connolly, B., et al. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-008-0194-8 · Cited by 19
Examining the effects of former cannabis use on cerebellum-dependent eyeblink conditioning in humans
Steinmetz, A. B., Edwards, C. R., Vollmer, J. M., Erickson, M. A., O’Donnell, B. F., Hetrick, W. P., & Skosnik, P. D. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2556-1 · Cited by 19
The Endocannabinoid System in the Physiology and Pathology of the Basal Ganglia
Gerdeman, G. L., & Fernández‐Ruíz, J. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_21 · Cited by 19
Is platelet release of 2-arachidonoyl-glycerol a mediator of cognitive deficits? An endocannabinoid theory of schizophrenia and arousal
Pryor, S. R. (2000) · Medical Hypotheses · doi:10.1054/mehy.2000.1100 · Cited by 19
Effects of cannabinoids on resting state functional brain connectivity: A systematic review
Lorenzetti, V., Gaillard, A., Thomson, D., Englund, A., & Freeman, T. P. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.105014 · Cited by 20
Cannabis, psychosis and the thalamus: A theoretical review
Vukadinovic, Z., Herman, M., & Rosenzweig, I. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.013 · Cited by 18
Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats
Calik, M. W., & Carley, D. W. (2016) · Journal of Negative Results in BioMedicine · doi:10.1186/s12952-016-0052-1 · Cited by 18
Regular cannabis and alcohol use is associated with resting-state time course power spectra in incarcerated adolescents
Thijssen, S., Rashid, B., Gopal, S., Nyalakanti, P. K., Calhoun, V. D., & Kiehl, K. A. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.05.045 · Cited by 20
Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and bipolar disorder patients with cannabis use
Hartberg, C. B., Lange, E. H., Lagerberg, T. V., Haukvik, U. K., Andreassen, O. A., Melle, I. S., & Agartz, I. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.11.019 · Cited by 18
Target and Tissue Selectivity Prediction by Integrated Mechanistic Pharmacokinetic-Target Binding and Quantitative Structure Activity Modeling
Vlot, A. H. C., de Witte, W. E. A., Danhof, M., van der Graaf, P. H., van Westen, G. J. P., & de Lange, E. C. M. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0172-7 · Cited by 20
A multimodal investigation of cerebellar integrity associated with high‐risk cannabis use
Sweigert, J., Pagulayan, K. F., Greco, G., Blake, M., Larimer, M. E., & Kleinhans, N. M. (2019) · Addiction Biology · doi:10.1111/adb.12839 · Cited by 18
Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB1 receptor in the ventromedial hypothalamus
Khan, A. U., Falconi‐Sobrinho, L. L., dos Anjos‐Garcia, T., Sampaio, M. D. F. D. S., Crippa, J. A. S., Menescal-de-Oliveira, L., & Coimbra, N. C. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05435-5 · Cited by 18
Medical cannabis and cognitive performance in middle to old adults treated for chronic pain
Sznitman, S. R., Vulfsons, S., Meiri, D., & Weinstein, G. (2020) · Drug and Alcohol Review · doi:10.1111/dar.13171 · Cited by 18
Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis
Petrella, C., Agostini, S., Alemà, G., Casolini, P., Carpino, F., Giuli, C., Improta, G., Linari, G., Petrozza, V., & Broccardo, M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01569.x · Cited by 18
CHANGES IN MOTOR AND LEARNING BEHAVIORS OF RATS PRENATALLY EXPOSED TO WIN 55212-2, A CANNABINOID RECEPTOR AGONIST
Shabani, M., Haghani, M., Sheibani, V., & Janahmadi, M. (2009) · Cited by 18
Fundamental and Clinical Evidence for Basal Ganglia Influences on Cognition
Middleton, F. A. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-326-2_2 · Cited by 18
Signal transduction of cannabinoid CB1 receptors in a smooth muscle cell line
Begg, M., Baydoun, A. R., Parsons, M. E., & Molleman, A. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0095j.x · Cited by 18
Synthesis of 6O-methyl-11C91-(2-chlorophenyl)-5-(4-methoxyphenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide: a potential PET ligand for CB1 receptors
Kumar, J. S. D., Prabhakaran, J., Arango, V., Parsey, R. V., Underwood, M. D., Simpson, N. R., Kassir, S. A., Majo, V. J., Heertum, R. L. V., & Mann, J. J. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.034 · Cited by 18
Brain Anatomical Alterations in Young Cannabis Users: Is it All Hype? A Meta-Analysis of Structural Neuroimaging Studies
Lorenzetti, V., Kowalczyk, M., Duehlmeyer, L., Greenwood, L.-M., Chye, Y., Yücel, M., Whittle, S., & Roberts, C. A. (2023) · Cannabis & Cannabinoid Research · doi:10.1089/can.2021.0099 · Cited by 17
Molecular imaging of levodopa-induced dyskinesias
Niccolini, F., Rocchi, L., & Politis, M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1854-x · Cited by 17
The endocannabinoid system within the dorsal lateral geniculate nucleus of the vervet monkey
Javadi, P., Bouskila, J., Bouchard, J., & Ptito, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.029 · Cited by 19
Pharmacological and molecular characterization of a dorsal root ganglion cell line expressing cannabinoid CB1 and CB2 receptors
Fan, Y., Hooker, B. A., Garrison, T. R., El-Kouhen, O. F., Idler, K. B., Holley-Shanks, R. R., Meyer, M. D., & Yao, B. B. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.020 · Cited by 17
Entopeduncular nucleus endocannabinoid system modulates sleep–waking cycle and mood in rats
Méndez‐Díaz, M., Caynas-Rojas, S., Santacruz, V. A., Ruiz‐Contreras, A. E., Aguilar‐Roblero, R. A., & Prospero-Garcia, O. E. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.04.003 · Cited by 17
Seasonal correlation of sporadic schizophrenia to Ixodes ticks and Lyme borreliosis
Fritzsche, M. (2002) · International Journal of Health Geographics · doi:10.1186/1476-072x-1-2 · Cited by 17

Authors: Glass, M., Faull, R. L. M., & Dragunow, M.
Affiliations: University of Auckland (NZ)
Corresponding author: Faull, R.L.M
ORCID: Glass, M
Faull, R.L.M
Dragunow, M
Venue: Neuroscience
Publisher: Elsevier BV
Published: 1997-02
Volume: 77
Issue: 2
Pages: 299-318
ISSN: 0306-4522 (ISSN-L)
DOI: 10.1016/s0306-4522(96)00428-9
OpenAlex: W2037811574
Cited by: 1,052
References: 68
Citations by year: 2026: 28 · 2025: 40 · 2024: 34 · 2023: 39 · 2022: 56 · 2021: 53 · 2020: 52 · 2019: 48 · 2018: 46 · 2017: 49 · 2016: 37 · 2015: 41 · 2014: 39 · 2013: 37 · 2012: 42
FWCI: 11.26
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neuroscience (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
Keywords: cannabinoid receptors, human brain, receptor distribution, receptor density, fetal brain, neonatal brain, hippocampal formation, neocortex, cortical laminar organization, thalamus, basal ganglia, midbrain, spinal cord, globus pallidus internus, globus pallidus externus, ventral pallidum, striatum, amygdala, entorhinal cortex, hemispheric lateralization, CP55,940
MeSH terms: Adult, Aged, Aged, 80 and over, Autoradiography, Brain, Brain Chemistry, Brain Mapping, Cannabinoids, Coloring Agents, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Myelin Sheath, Pregnancy, Receptors, Drug, Spinal Cord, Receptors, Cannabinoid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks